The chemical class known as NHE-9 Inhibitors comprises a range of compounds selected for their ability to modulate the activity of the sodium/hydrogen exchanger 9 (NHE-9). This classification is not characterized by a uniform chemical structure but by their functional potential to influence the biological activities associated with NHE-9. The development of these inhibitors is guided by an understanding of NHE-9's role in cellular ion transport and pH regulation, which are critical for maintaining cellular homeostasis and various physiological processes. NHE-9, as a sodium/hydrogen exchanger, plays a pivotal role in regulating intracellular pH and ion concentration gradients. This function is central to many cellular processes, including cell volume regulation, intracellular signaling, and the maintenance of metabolic activities. The inhibitors in this class target these fundamental processes, aiming to modulate the ion exchange mechanism of NHE-9. By influencing this mechanism, these inhibitors can alter the cellular and intracellular environment, impacting the pH balance and ion homeostasis. This modulation is crucial because it can affect a wide range of cellular functions, from enzyme activities to signaling pathways, and even gene expression.
Furthermore, the significance of NHE-9 in endosomal function underscores another potential target area for these inhibitors. NHE-9 is involved in endosomal acidification, an essential process for protein sorting, trafficking, and degradation. Inhibitors targeting NHE-9 can therefore have implications for these endosomal functions, influencing cellular processing and signaling mechanisms. Additionally, the role of NHE-9 in neurological functions and its association with certain neurodevelopmental disorders highlight the broader impact these inhibitors can have. By modulating NHE-9 activity, these compounds can influence neuronal signaling and development, shedding light on the intricate balance of ion transport and pH regulation in neurological processes. In summary, the chemical class of NHE-9 Inhibitors is characterized by their diverse mechanisms of action, each targeting different aspects of the biological pathways and processes associated with NHE-9. The development and study of these inhibitors are driven by ongoing research into the molecular biology of NHE-9 and its role in health and disease. This research is integral to advancing our understanding of cellular ion transport mechanisms and their significance in physiological and pathological states.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
Could possibly inhibit SLC9A9 by affecting sodium gradients crucial for its function. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Could possibly inhibit SLC9A9 by disrupting endosomal acidification. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Could possibly inhibit SLC9A9 by affecting vacuolar-type H+-ATPase, influencing endosomal function. | ||||||
Pantoprazole | 102625-70-7 | sc-204830 sc-204830A | 100 mg 500 mg | $89.00 $255.00 | 2 | |
Could possibly inhibit SLC9A9 by altering pH homeostasis, impacting its activity. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Could possibly inhibit SLC9A9 by influencing pH levels and impacting its function. | ||||||
Cariporide | 159138-80-4 | sc-337619A sc-337619 | 10 mg 100 mg | $87.00 $729.00 | 31 | |
Could possibly inhibit SLC9A9 by impacting ion transport and pH regulation mechanisms. | ||||||
SR 48692 | 146362-70-1 | sc-363290 sc-363290A sc-363290B sc-363290C sc-363290D | 5 mg 25 mg 100 mg 500 mg 1 g | $159.00 $605.00 $2374.00 $10710.00 $21410.00 | 2 | |
Could possibly inhibit the activity of SLC9A9. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Could possibly inhibit SLC9A9 by influencing signaling pathways associated with its function. | ||||||